Experimental ischemic pancreatitis: Treatment with albumin

Hilary Sanfey, Patrick J. Broe, John L. Cameron

Research output: Contribution to journalArticlepeer-review

Abstract

Acute pancreatitis was initiated in the isolated ex vivo, perfused canine pancreas preparation by exposing the gland to a 2 hour period of ischemia before a 4 hour perfusion period. The pancreatitis was manifested by edema formation, weight gain, and hyperamylasemia. When the osmotically active agent albumin was added to the perfusate at the end of the ischemic period, virtually no edema developed, weight gain was minimal, and the amylase level remained within normal limits during the subsequent 4 hour perfusion period. This suggests that a change in capillary permeability may be an early step in the pathogenesis of ischemia-induced pancreatitis in this experimental model.

Original languageEnglish (US)
Pages (from-to)297-300
Number of pages4
JournalThe American Journal of Surgery
Volume150
Issue number3
DOIs
StatePublished - Sep 1985
Externally publishedYes

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Experimental ischemic pancreatitis: Treatment with albumin'. Together they form a unique fingerprint.

Cite this